65,437 trials
Superficial Basal Cell Carcinoma
Primary: Number of Participants With Sustained Clearance Rate of Superficial Basal Cell Carcinoma (sBCC) — 119 participants
Keratosis
Primary: Number of Participants Who Experienced an Adverse Event — 472 participants
Gingival Diseases
Primary: Dental Plaque Index — 2.48; 2.42 Units on a scale — p=0.05
Dental Plaque
Primary: Gingival Margin Plaque Index — 15.4; 12.81 Units on a scale — p=0.05
Influenza
Primary: Occurrence of Solicited Adverse Events Among All Subjects — 0; 0; 10; 1 Participants
Colic
Primary: Hours Per Day of Fuss/Cry — 2.20; 1.48 hours per day
Diarrhea · Constipation
Primary: Reduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group — 12; 19 days of constipation or diarrhea
Dental Plaque
Primary: Mean Gingival Plaque Units — 13.38; 14.29 Units on a scale — p=0.05
Hepatitis A · Measles · Mumps
Primary: Participants With 1 or More Serious Vaccine-Related Adverse Experiences — 0; 1 participants
Depression
Primary: Beck Depression Inventory II (Beck, Steer & Brown, 1996) — 14.27; 16.93 Points on a scale
Dental Plaque
Primary: Dental Plaque Index — 3.12; 2.90; 2.92; 2.94 Units on a scale — p=<0.05
Gingival Diseases
Primary: Dental Plaque Index — 2.79; 2.82; 1.99 Units on a scale — p=<0.05
Asthma · Allergic Rhinitis
Primary: Change From Baseline for Daytime Asthma Symptom Score — 0.32; 0.16; 0.29; 0.13 Units on scale — p=0.015
Influenza
Primary: Antibody Responses in Nasal Secretions to Influenza A/H1N1 and A/H3N2 at 14 Days After Intranasal Immunization. — 3; 3; 5; 0 Participants
Academic Achievement in Math
Primary: Math Scores on the Texas Assessment of Knowledge and Skills (TAKS) — 65.1; 70.0 percentile